The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase - Hacke, W; Albers, G; Al Rawi, Y (Stroke, 2005)